Who is affected by this change?

This affects Independence Blue Cross ENT (Ear, Nose & Throat), Neurosurgery, Audiology providers on Medicare Advantage plans.

When does this change take effect?

This change is effective Apr 2, 2025.

Back to dashboard

Medicare AdvantageCoverageMedium impact

MA11.039e, Cochlear Implantation

Independence Blue Cross·ENT (Ear, Nose & Throat), Neurosurgery, Audiology·Medical Policy

Effective date

Apr 2, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Medicare Advantage policy MA11.039e for Cochlear Implantation has been reissued and will take effect April 2, 2025. This is a policy update that may contain changes to coverage criteria, prior authorization requirements, or documentation standards for cochlear implant procedures and services.

Action Required

Action needed

By April 2, 2025: Billing team must review the full MA11.039e Cochlear Implantation policy at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation standards. Update billing procedures and staff training accordingly for all cochlear implant-related services under Medicare Advantage plans.

Related policy hubs

Independence Blue Cross policies ENT (Ear, Nose & Throat)Neurosurgery Audiology